JP2017534654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017534654A5 JP2017534654A5 JP2017525909A JP2017525909A JP2017534654A5 JP 2017534654 A5 JP2017534654 A5 JP 2017534654A5 JP 2017525909 A JP2017525909 A JP 2017525909A JP 2017525909 A JP2017525909 A JP 2017525909A JP 2017534654 A5 JP2017534654 A5 JP 2017534654A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- mediated
- caused
- gardnerella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010040872 skin infection Diseases 0.000 claims 26
- 239000008194 pharmaceutical composition Substances 0.000 claims 19
- 208000002874 Acne Vulgaris Diseases 0.000 claims 15
- 206010000496 acne Diseases 0.000 claims 15
- 230000001404 mediated effect Effects 0.000 claims 15
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 15
- 241000207202 Gardnerella Species 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000003814 drug Substances 0.000 claims 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 6
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims 6
- 208000037009 Vaginitis bacterial Diseases 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 6
- 241000894006 Bacteria Species 0.000 claims 5
- 241000186427 Cutibacterium acnes Species 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000011200 topical administration Methods 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 3
- 229940072107 ascorbate Drugs 0.000 claims 3
- 235000010323 ascorbic acid Nutrition 0.000 claims 3
- 239000011668 ascorbic acid Substances 0.000 claims 3
- 201000007032 bacterial conjunctivitis Diseases 0.000 claims 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 3
- AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 claims 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 239000010452 phosphate Substances 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 229940043131 pyroglutamate Drugs 0.000 claims 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 3
- 229960001860 salicylate Drugs 0.000 claims 3
- 229940086735 succinate Drugs 0.000 claims 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 3
- 229940095064 tartrate Drugs 0.000 claims 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 241000207201 Gardnerella vaginalis Species 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229940055019 propionibacterium acne Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462080212P | 2014-11-14 | 2014-11-14 | |
| US62/080,212 | 2014-11-14 | ||
| PCT/US2015/060851 WO2016077818A1 (en) | 2014-11-14 | 2015-11-16 | Method for treating, preventing, or reducing the risk of skin infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017534654A JP2017534654A (ja) | 2017-11-24 |
| JP2017534654A5 true JP2017534654A5 (enExample) | 2018-12-27 |
Family
ID=55955188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525909A Withdrawn JP2017534654A (ja) | 2014-11-14 | 2015-11-16 | 皮膚感染症を処置する、予防する、またはその危険性を低減するための方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10471046B2 (enExample) |
| EP (1) | EP3217974A4 (enExample) |
| JP (1) | JP2017534654A (enExample) |
| KR (1) | KR20170084200A (enExample) |
| CN (1) | CN107205989A (enExample) |
| AR (1) | AR102666A1 (enExample) |
| AU (1) | AU2015346023A1 (enExample) |
| BR (1) | BR112017009989A2 (enExample) |
| CA (1) | CA2967825A1 (enExample) |
| CL (1) | CL2017001245A1 (enExample) |
| CR (1) | CR20170196A (enExample) |
| EA (1) | EA201791051A1 (enExample) |
| HK (1) | HK1244211A1 (enExample) |
| IL (1) | IL252197A0 (enExample) |
| MX (1) | MX389005B (enExample) |
| NI (1) | NI201700057A (enExample) |
| PH (1) | PH12017500887A1 (enExample) |
| SG (1) | SG11201703856VA (enExample) |
| SV (1) | SV2017005444A (enExample) |
| UY (1) | UY36402A (enExample) |
| WO (1) | WO2016077818A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016198691A1 (en) | 2015-06-11 | 2016-12-15 | Basilea Pharmaceutica Ag | Efflux-pump inhibitors and therapeutic uses thereof |
| EP3551611A1 (en) * | 2016-12-09 | 2019-10-16 | Celtaxsys Inc. | Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase |
| CN107721943A (zh) * | 2017-10-26 | 2018-02-23 | 沈阳药科大学 | 含联芳基腙结构的噁唑烷酮类化合物及其制备方法 |
| KR20190130243A (ko) | 2018-05-14 | 2019-11-22 | (주)텔리언 | 트러스트 인덱스를 이용한 공유경제 시스템 및 방법 |
| MX2021015652A (es) | 2019-06-25 | 2022-02-03 | Amtixbio Co Ltd | Nuevo derivado del acido aminoalcanoico que contiene un grupo bifenilo y una composicion farmaceutica antifungica que comprende el mismo. |
| CN115677679A (zh) * | 2021-07-26 | 2023-02-03 | 沈阳药科大学 | 含联芳基腙结构的噁唑烷酮化合物及其制备方法和应用 |
| CN120794967A (zh) * | 2024-04-10 | 2025-10-17 | 沈阳药科大学 | 联芳基噁唑烷酮类化合物及其应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES332272A1 (es) | 1965-10-20 | 1967-11-16 | Milwaukee Chaplet & Mfg Company Inc | Un dispositivo regulador de programa. |
| GB1185685A (en) | 1966-01-11 | 1970-03-25 | Quinoderm Ltd | Method of Making Pharmaceutical Compositions |
| US3418055A (en) | 1967-04-03 | 1968-12-24 | Schwartzman Gilbert | Pressure operated applicator and cap construction |
| US3410645A (en) | 1967-05-08 | 1968-11-12 | Schwartzman Gilbert | Concave diaphragm applicator |
| US3535422A (en) | 1968-03-11 | 1970-10-20 | Stiefel Laboratories | Stable benzoyl peroxide composition |
| US3669323A (en) | 1969-12-12 | 1972-06-13 | American Can Co | One-way valve insert for collapsible dispensing containers |
| US4056611A (en) | 1973-04-16 | 1977-11-01 | Stiefel Laboratories, Inc. | Therapeutic composition |
| GB1541463A (en) | 1975-10-11 | 1979-02-28 | Lion Dentifrice Co Ltd | Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase |
| US4620648A (en) | 1982-07-06 | 1986-11-04 | Dab-O-Matic Corp. | Pressure-responsive valve |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4985459A (en) | 1984-02-08 | 1991-01-15 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
| US4693623A (en) | 1984-03-02 | 1987-09-15 | Dab-O-Matic Corp. | Pressure-responsive valve for an applicator |
| US4999186A (en) | 1986-06-27 | 1991-03-12 | The Procter & Gamble Company | Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn |
| US4937370A (en) | 1987-06-02 | 1990-06-26 | The Procter & Gamble Company | Novel chromophores, sunscreen compositions and methods for preventing sunburn |
| US4960764A (en) | 1987-03-06 | 1990-10-02 | Richardson-Vicks Inc. | Oil-in-water-in-silicone emulsion compositions |
| US4800197A (en) | 1987-07-17 | 1989-01-24 | Richardson-Vicks Inc. | Anti-acne composition |
| US4891228A (en) | 1988-02-02 | 1990-01-02 | Richardson-Vicks Inc. | Medicated cleansing pads |
| US4891227A (en) | 1988-02-02 | 1990-01-02 | Richardson-Vicks Inc. | Medicated cleansing pads |
| US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
| US5087445A (en) | 1989-09-08 | 1992-02-11 | Richardson-Vicks, Inc. | Photoprotection compositions having reduced dermal irritation |
| US5073372A (en) | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
| US5073371A (en) | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
| AU667198B2 (en) | 1991-11-01 | 1996-03-14 | Pharmacia & Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| US6107482A (en) | 1995-03-27 | 2000-08-22 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
| RU2171252C2 (ru) | 1995-09-22 | 2001-07-27 | Вакунага Фармасьютикал КО., Лтд. | Аминосоединение для получения новых производных пиридонкарбоновой кислоты или их солей |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| BR0111280A (pt) | 2000-06-05 | 2003-06-10 | Dong A Pharm Co Ltd | Novos derivados de oxazolidinona e um processo para a preparação dos mesmos |
| US20130059774A1 (en) * | 2000-08-01 | 2013-03-07 | Mahesh Vithalbhai Patel | Efflux pump inhibitors |
| US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| BRPI0408117A (pt) | 2003-03-05 | 2006-03-01 | Rib X Pharmaceuticals Inc | compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos |
| EP1646617A2 (en) | 2003-06-03 | 2006-04-19 | Rib-X Pharmaceuticals, Inc. | Sulfonamide compounds and methods of making and using the same |
| WO2005012271A2 (en) | 2003-07-29 | 2005-02-10 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
| AU2004267007C1 (en) * | 2003-06-03 | 2010-04-29 | Melinta Subsidiary Corp. | Biaryl heterocyclic compounds and methods of making and using the same |
| JP2007500707A (ja) | 2003-07-29 | 2007-01-18 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法 |
| JP2007514782A (ja) | 2003-12-17 | 2007-06-07 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法 |
| WO2006022794A1 (en) | 2004-07-28 | 2006-03-02 | Rib-X Pharmaceuticals, Inc. | Biaryl heterocyclic compounds and methods of making and using the same |
| EP2816033A1 (en) | 2004-07-30 | 2014-12-24 | Abbvie Inc. | Preparation of pyridonecarboxylic acid antibacterials |
| ES2901955T3 (es) | 2004-10-08 | 2022-03-24 | Abbvie Inc | Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina) |
| ATE549016T1 (de) | 2005-04-11 | 2012-03-15 | Abbott Lab | Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe |
| US8399660B2 (en) | 2005-06-08 | 2013-03-19 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of triazoles |
| US8470985B2 (en) | 2005-08-24 | 2013-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| JP2009506066A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| WO2011139832A2 (en) | 2010-04-28 | 2011-11-10 | Rib-X Pharmaceuticals, Inc. | Method for treating mycobacterial infections |
-
2015
- 2015-11-16 KR KR1020177015770A patent/KR20170084200A/ko not_active Withdrawn
- 2015-11-16 CR CR20170196A patent/CR20170196A/es unknown
- 2015-11-16 EP EP15858675.0A patent/EP3217974A4/en active Pending
- 2015-11-16 MX MX2017006319A patent/MX389005B/es unknown
- 2015-11-16 EA EA201791051A patent/EA201791051A1/ru unknown
- 2015-11-16 SG SG11201703856VA patent/SG11201703856VA/en unknown
- 2015-11-16 CA CA2967825A patent/CA2967825A1/en active Pending
- 2015-11-16 BR BR112017009989-6A patent/BR112017009989A2/pt not_active Application Discontinuation
- 2015-11-16 CN CN201580073501.5A patent/CN107205989A/zh not_active Withdrawn
- 2015-11-16 AU AU2015346023A patent/AU2015346023A1/en not_active Abandoned
- 2015-11-16 HK HK18103723.8A patent/HK1244211A1/zh unknown
- 2015-11-16 JP JP2017525909A patent/JP2017534654A/ja not_active Withdrawn
- 2015-11-16 US US14/942,021 patent/US10471046B2/en active Active
- 2015-11-16 AR ARP150103729A patent/AR102666A1/es unknown
- 2015-11-16 UY UY0001036402A patent/UY36402A/es not_active Application Discontinuation
- 2015-11-16 WO PCT/US2015/060851 patent/WO2016077818A1/en not_active Ceased
-
2017
- 2017-05-10 IL IL252197A patent/IL252197A0/en unknown
- 2017-05-12 PH PH12017500887A patent/PH12017500887A1/en unknown
- 2017-05-12 NI NI201700057A patent/NI201700057A/es unknown
- 2017-05-15 CL CL2017001245A patent/CL2017001245A1/es unknown
- 2017-05-15 SV SV2017005444A patent/SV2017005444A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528600A5 (enExample) | ||
| JP2009102342A5 (enExample) | ||
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| JP2011173928A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| EA201690102A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
| JP2017528503A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| JP2009536176A5 (enExample) | ||
| NO20092542L (no) | Antibakterielle kinolin-derivater | |
| FI3766876T3 (fi) | Kinolonijohdannaista sisältävä farmaseuttinen formulaatio | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| TN2015000386A1 (en) | Formulations of organic compounds | |
| JP2015537009A5 (enExample) | ||
| JP2012508256A5 (enExample) | ||
| PE20210415A1 (es) | Forma de dosificacion farmaceutica administrable por via oral con liberacion modificada | |
| RU2016136351A (ru) | Пиррол-замещенное производное индолона, способ его получения, включающая его композиция и применение | |
| JP2016515550A5 (enExample) | ||
| JP2013536837A5 (enExample) | ||
| HRP20250002T1 (hr) | Ampreloksetin, namijenjen upotrebi u liječenju neurogene ortostatske hipotenzije | |
| RU2019111873A (ru) | Новые антимикробные соединения, их применение для лечения инфекций млекопитающих и новый метаболический механизм | |
| NO20092547L (no) | Antibakterielle kinolin-derivater | |
| JP2013539466A5 (enExample) | ||
| RU2018130097A (ru) | Лечение экземы кистей |